Clinical Trial Update: A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of the Ebola vaccine cAd3-EBOZ conducted in healthy adults in Switzerland has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• cAd3-EBOZ

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Ebola Vaccines | Phase 1, Phase 2 | Status: COMPLETED